Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

This study has been completed.
Sponsor:
Information provided by:
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT00710528
First received: July 1, 2008
Last updated: August 29, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
No publications provided by Gilead Sciences

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):